Abstract
HIV-Selectest is a serodiagnostic enzyme immunoassay (EIA), containing p6 and gp41 peptides, designed to differentiate between vaccine-induced antibodies and true infections. A rapid test version of the HIV-Selectest was developed. Both assays detected HIV antibodies in men and women within 2 to 4 weeks of infection, with sensitivity similar to third-generation EIAs.
Original language | English (US) |
---|---|
Pages (from-to) | 281-285 |
Number of pages | 5 |
Journal | Journal of clinical microbiology |
Volume | 48 |
Issue number | 1 |
DOIs |
|
State | Published - Jan 2010 |
ASJC Scopus subject areas
- Microbiology (medical)